1. Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation-positive non-small cell lung cancers: an update for recent advances in therapeutics;J Oncol Pharm Pract,2016
2. Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity;Arch Toxicol,2015
3. Epidermal growth factor receptor mutation (EGFR) testing for prediction of response to EGFR-targeting tyrosine kinase inhibitor (TKI) drugs in patients with advanced non-small-cell lung cancer: an evidence-based analysis;Ont Health Technol Assess Ser,2010
4. Survival and prognostic factors in non-small cell lung cancer patients with mutation of the EGFR gene treated with tyrosine kinase inhibitors in a Peruvian hospital;Am J Cancer Res,2019
5. ErbB Receptors and Cancer;Methods Mol Biol,2017